The Safety and Immunogenicity of the mRNA-BNT162b2 SARS-CoV-2 Vaccine in Hemodialysis Patients

Overview of attention for article published in Frontiers in immunology, June 2021

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 62 Dimensions

Readers on

mendeley: 126 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 62 publications that cite this research output.

62

The most recent citing publications are shown below. View all 62 publications that cite this research output on Dimensions.

The humoral immune response to the BNT 162B2 vaccine in pediatrics on renal replacement therapy

Article in Pediatric Transplantation (March 2024)

Effectiveness and safety of immune response to SARS‑CoV‑2 vaccine in patients with chronic kidney disease and dialysis: A systematic review and meta‑analysis

Article in Biomedical Reports (March 2024)

Avaliação da resposta imune humoral a diferentes vacinas contra a COVID-19 em pacientes submetidos à hemodiálise de manutenção

Article in Brazilian Journal of Nephrology (December 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.